Christoph Lengauer/Third Rock: focused on new targetdiscovery, company concepts that explore well-established targets & find ways w/ platforms that make drugging them possible.$83M Series A round 4newco MOMA Tx. Diagnostics- Foundation Medicine & Thrive- early cancer diagnosis
choke size 32/64” at well head flowing pressure 89-149 Pounds per Square Inch (PSI) from Wargal Formation (Exploratory Target).
The discovery of Chanda Well # 05 is the result of aggressive exploration strategy adopted by the Company. It has opened a new avenue in KParea for 4/4
Free Drug Discovery and Development forums | Hosted by our parent company, @Evotec, throughout the UK & Europe this year. Industry leading experts will share their experiences derived from leading innovation from target to IND and high-end CMC |